G. Engelhardt
About
In The Last Decade
G. Engelhardt
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 122
- Pharmacology 726
- Physiology 200
- Molecular Biology 197
- Organic Chemistry 184
- Pharmacology 169
Countries citing papers authored by G. Engelhardt
This map shows the geographic impact of G. Engelhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Engelhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Engelhardt more than expected).
Fields of papers citing papers by G. Engelhardt
This network shows the impact of papers produced by G. Engelhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Engelhardt. The network helps show where G. Engelhardt may publish in the future.
Co-authorship network of co-authors of G. Engelhardt
This figure shows the co-authorship network connecting the top 25 collaborators of G. Engelhardt. A scholar is included among the top collaborators of G. Engelhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Engelhardt. G. Engelhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 78 | |
| 2 | 1 | |
| 3 | 83 | |
| 4 | Role of caffeine in combined analgesic drugs from the point of view of experimental pharmacology. | 21 |
| 5 | 5 | |
| 6 | Effects of acetylsalicylic acid, paracetamol and caffeine and a combination of these substances on kidney glutathione levels. | 12 |
| 7 | 16 | |
| 8 | 154 | |
| 9 | 8 | |
| 10 | 94 | |
| 11 | 191 | |
| 12 | 282 | |
| 13 | 8 | |
| 14 | 13 | |
| 15 | [Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)]. | 31 |
| 16 | [On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist (author's transl)]. | 5 |
| 17 | 5 | |
| 18 | 6 | |
| 19 | 1 | |
| 20 | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.